Atlantic American Corporation (NASDAQ:AAME)
Atlantic American Corporation (NASDAQ:AAME) represented a move of 0 percent or $-0.02 per share and closed its previous day trading session at $2.68. 0 Shares were traded in the last trading session with an Average Volume of 5.11 Million Shares. The stock currently has a Market Capitalization of 54.73 Million.
Atlantic American Corporation is a holding company that operates through its subsidiaries in well-defined specialty markets of the life, health, property and casualty insurance industries.
The stock traded between $2.20 and $4.00 over 1-Year time period showing its price to sales ratio of 0.3. Atlantic American Corporation (NASDAQ:AAME) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-6.37 and 200-Day Simple Moving Average of $-8.11. Its Price to Free Cash Flow is 0 and Price to Book of 0.54.
Analyst’s recommended the stock as 0 where 1 represents Strong Buy and 5 represents Sell.
Aethlon Medical, Inc. (NASDAQ:AEMD)
In the last trading session, Aethlon Medical, Inc. (NASDAQ:AEMD) added its value by 0% closing at the price of $1.3. The stock currently has market capitalization of 23.22 Million, with average volume of 290.48 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Aethlon Medical, Inc. (NASDAQ:AEMD) is showing beta of 2.15. This particular value of beta suggests that Aethlon Medical, Inc. (NASDAQ:AEMD) has historically moved 215% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Aethlon Medical, Inc. (NASDAQ:AEMD) is at $-0.3.
The stock currently has RSI of 55.92. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Aethlon Medical, Inc. is a development stage medical device company focused on expanding the applications of our Hemopurifier (R) platform technology, which is designed to rapidly reduce the presence of infectious viruses and other toxins from human blood. In this regard, its core focus is the development of therapeutic devices that treat acute viral conditions, chronic viral diseases and pathogens targeted as potential biological warfare agents. The Hemopurifier(R) combines the established scientific principles of affinity chromatography and hemodialysis as a means to mimic the immune system’s response of clearing viruses and toxins from the blood before cell and organ infection can occur. The Hemopurifier(R) cannot cure viral conditions but can prevent virus and toxins from infecting unaffected tissues and cells. The company has completed pre-clinical blood testing of the Hemopurifier(R) to treat HIV and Hepatitis-C, and have completed human safety trials on Hepatitis-C infected patients in India.
Aethlon Medical, Inc. (NASDAQ:AEMD) topped its 52-week high price of $2.04 on 03/15/18 and 52-Week Low Price of $0.82 on 08/30/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 11.86% and monthly volatility of 9.07% respectively.